Molecular Matrix
-
Hospitals
Molecular Matrix, Inc. Receives a 510K Clearance for its Revolutionary Bone Graft Substitute Technology, Osteo-P™
SACRAMENTO, CALIF. (PRWEB) JANUARY 17, 2018 Molecular Matrix, Inc (MMI) today announced the FDA clearance (510k) of Osteo-P™, a value-driven, effective musculoskeletal…
Read More »